Brexpiprazole for agitation in clinically relevant patient subgroups: a post hoc analysis of efficacy and safety in patients with agitation associated with dementia due to Alzheimer’s disease

Curr Med Res Opin. 2025 Aug 23:1-16. doi: 10.1080/03007995.2025.2552278. Online ahead of print. ABSTRACT OBJECTIVE: To explore the efficacy and safety of brexpiprazole for the treatment of agitation symptoms in clinically relevant subgroups of patients with dementia...